ILMN

#588
Illumina Inc
130.09 USD
+2.47%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
130.01
130.60
Intervallo Annuale
69.88
155.47
Variazione giornaliera
+2.47%
Variazione Mensile
+8.43%
Variazione di 6 mesi
+43.57%
Variazione Annuale
+73.59%
Chiusura Precedente
126.96
Apertura
130.22
Bid
Ask
Minimo
130.01
High
130.60
Volume
237
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 19.89 B
  • Employee 8 650
  • Founded 1998
  • CEO Jacob Thaysen
  • Website www.illumina.com
  • Headquarter Delaware, United States
  • FIGI BBG000DSMS70
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
24.68
Rapporto prezzo/fatturato
4.83

Illumina Inc

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

Notizie